Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » AstraZeneca

AstraZeneca

Sep 22, 2020

Another Protocol Released

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Sep 15, 2020

Data to Look Over

According to the Los Angeles Times, National Institutes of Health officials are concerned about the possible side effect reported by a COVID-19 vaccine trial.

Sep 14, 2020

Back Up in the UK

After a pause, AstraZeneca has resumed its COVID-19 vaccine clinical trial in the UK, according to NPR.

Sep 14, 2020

Thermo Fisher Scientific, AstraZeneca, U of Nebraska Partner for Protein Biomarker Discovery

Planned and ongoing studies will use standardized plasma protein profiling workflows to discover biomarkers for a range of conditions.

Sep 10, 2020

On Pause

The Washington Post reports AstraZeneca's pausing of its candidate vaccine trial indicates the science is being followed.

Sep 01, 2020

Another Phase III Starts

According to Reuters, AstraZeneca has begun enrolling participants into a late-stage study of its candidate SARS-CoV-2 vaccine.

Aug 21, 2020

RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes

The firms will initially use RenalytixAI's KidneyIntelX platform to help improve outcomes for patients with chronic kidney disease and its complications. 

Jul 20, 2020

Additional Early Vaccine Results

The New York Times reports two additional investigational vaccines appear to generate an immune response against SARS-CoV-2.

Jun 04, 2020

Tumor Mutational Burden in Blood May Predict Immunotherapy Response in Head, Neck Cancer

In a retrospective study, investigators saw a survival benefit among head and neck cancer patients with high TMB treated with checkpoint inhibitors. 

May 26, 2020

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

ArcherDx will develop sequencing-based circulating tumor DNA assays for use in AstraZeneca's recently launched Phase III MERMAID-1 trial of durvalumab (Imfinzi).

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.